Copyright
©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 287-294
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.287
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.287
Figure 1 Combined resolution rate and 95%CIs of studies on initial treatment of peritoneal dialysis-related peritonitis with ceftazidime plus a glycopeptide vs a first generation cephalosporin plus an aminoglycoside.
Figure 2 Combined resolution rate and 95%CIs of studies on initial treatment of peritoneal dialysis-related peritonitis with ceftazidime plus a glycopeptide vs a glycopeptide plus an aminoglycoside.
- Citation: Barretti P, Doles JVP, Pinotti DG, El Dib RP. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol 2015; 4(2): 287-294
- URL: https://www.wjgnet.com/2220-6124/full/v4/i2/287.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i2.287